Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Aptiv €750 million senior notes offering
We advised Aptiv on the investment-grade debt offering
Province of British Columbia $2 billion global bond offering
The investment-grade bonds are due 2034
COAM International $650 million notes offering
The investment-grade notes are due 2029
Royalty Pharma $1.5 billion senior notes offering
We advised Royalty Pharma on its investment-grade notes offering
Health Care Service Corporation $2.5 billion notes offering
The investment-grade debt offering consists of three tranches
UGI $700 million convertible senior notes offering
The 5% convertible senior notes are due 2028
Vitru merger and listing migration from Nasdaq to São Paulo Stock Exchange
We advised Vitru on the transaction
Velocity Vehicle Group $500 million senior notes offering
The high-yield notes are due 2029
Verisk $600 million senior notes offering and concurrent tender offer
We advised Verisk in connection with the transactions
Export Development Canada $1 billion global green bond offering
The investment-grade bonds are due 2034